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In the preceding paper (1) the production and the clinical features 
of experimental Type III pneumococcus pneumonia in monkeys of 
the M. cynomolgos species were described.  The experimental disease 
in  its  clinical  aspects  closely  resembles lobar  pneumonia in  man. 
The infection in these animals results in a pneumonic lesion of lobar 
distribution  which  tends  to  spread  and  which  terminates  after  a 
variable period in spontaneous recovery or death.  The irregularity 
of the course of the disease in individual animals is striking, but when 
septicemia  is  present  the  mortality  rate  increases  proportionately 
with the number of organisms in the circulating blood.  Thus, the 
height of the septicemia, irrespective of the size of the infecting dose, 
was found to be the most valuable objective index of the severity of 
the disease in a given animal. 
In  earlier  studies,  Avery  and  Dubos  (2)  showed that  a  specific 
enzyme of bacterial  origin was  capable  of protecting mice against 
subsequent infection with Type III Pneumococcus, and of exerting 
a  curative  effect on  infections already  established.  The beneficial 
effect of the enzyme was demonstrated to be due to its capacity to 
decompose the specific capsular polysaccharide of Type III Pneumo- 
coccus, thus rendering the bacteria readily susceptible to phagocytosis 
by the cells of the animal body. 
Studying the effect of the enzyme upon a  dermal infection with 
Type III Pneumococcus in rabbits,  Goodner, Dubos, and Avery (3) 
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found that 95 per cent of untreated rabbits died, while of those which 
were treated with enzyme, 95 per cent recovered.  With the amounts 
of enzyme employed, there was found to be a degree of infection which, 
although influenced by  enzyme,  terminated fatally.  Goodner  and 
Dubos  (4)  later  showed  that  the  amount  of enzyme  required  for 
successful therapy increased with the height of the septicemia. 
Since it had been found possible  regularly to produce an experi- 
mental pneumonia in monkeys very similar to lobar pneumonia in 
man,  it  was of interest  to  determine the  effect of treatment with 
specific enzyme upon the course and outcome of the disease.  It was 
fully recognized that  the  methods employed in  the  production  of 
enzyme were  not  standardized,  and  that  different lots  of  enzyme 
varied  considerably in  their potency.  Certain lots even contained 
substances which were toxic for animals.  In spite of these technical 
imperfections,  the  treatment  of  experimental  lobar  pneumonia  in 
monkeys was begun.  The present paper reports the results of enzyme 
treatment of experimental Type III pneumococcus pneumonia in 40 
monkeys.  All animals were treated within the first 3 days after infec- 
tion.  Consequently, they have been divided into groups on the basis 
of the height of the septicemia during the first 3 days of the disease. 
This classification affords a  basis for comparison of the results with 
the 68 untreated monkeys included in the preceding paper. 
EXPERIMENTAL 
Selection of Animals for Treatment.--Because of the extreme variations in the 
severity of the experimental disease in different monkeys, it was not feasible to 
select alternate animals for treatment and controls.  Only after the disease was 
established was it possible to determine which animals in a given experiment 
were the most likely to succumb.  Consequently, the sickest animals in each 
experimental group (2 to 6 in number) were chosen for enzyme therapy.  The 
criteria on which the choice was based were the fever, the number of circulating 
leukocytes, the X-ray evidence, the general condition of the animal, and especially 
the height of the septicemia. 
Enzyme.--The preparations of the enzyme were made by methods previously 
described (5); but from time to time minor changes were introduced in attempts 
to produce a more potent product.  The enzyme content of the different prepara- 
tions varied from 2 to 20 units per cc. 
Procedure of Treatment.--Practically  all therapeutic experiments were carried 
out during the winter and spring, when experimental  conditions were more nearly FRANCIS,  TERRELL,  DUBOS~ AND  AVERY  643 
stable and the smaller doses of organisms were more efficient  in producing typical 
pneumonia.  During  the  period  of  treatment  the  animal's  temperature  was 
recorded, repeated blood cultures and blood counts were made, and the X-rays 
were carefully studied for evidence of extension or regression of the pneumonic 
process.  A  blood culture  and  white blood cell count were made immediately 
before treatment.  Because of variation in the enzyme content of different lots, 
the usual procedure was to administer  10 cc. of the enzyme preparation  intra- 
venously.  Further treatment was based upon the response to the first injection, 
the severity of the disease, and the potency of the particular preparation of enzyme. 
Additional treatments were given as often  as  three  times  daily, either intrave- 
nously, intraperitoneally, or by both routes simultaneously.  When enzyme therapy 
was employed, treatment was always begun within the first 3 days after infection. 
TABLE  I 
Mortality in Experimental Type III Pneumococcus Pneumonia in Monkeys 
Receiving Enzyme Thera ~y* 
Diagnosis  No. of  No.  No. died  animals  recovered 
Pneumonia without septicemia ............  8  8  0 
Pneumonia with septicemia (1-250 per cc.).  15  15  0 
Pneumonia  with  septicemia  (250--2000 per 
cc.) ...................................  9  8  ! 
Pneumonia with septicemia (2000 or greater 
per cc.) ...............................  8  1  7 
Total .................................  40  i  32 
Mortality 
p~r Cent 
0 
0 
11.1 
87.5 
20.0 
* Classified  on the basis of height of septicemia during first 3 days. 
No attempt  was made to ascertain  the minimal amount of enzyme required  in 
individual monkeys, but,  rather,  treatment  was intensively employed until  the 
result was assured. 
RESULTS 
In the entire series of 40 monkeys with pneumonia, in which enzyme 
therapy  was  employed,  the  mortality  rate  was  20  per  cent.  The 
animals  have  been  subdivided  into  four groups based  on the height 
of the septicemia during the first 3 days of the disease (Table I).  The 
distribution  of the cases is comparable to that of the untreated series 
(1).  With  one  exception,  the  fatal  cases  fall  into  the  group with 
extreme septicemia and marked prostration.  The height of the septi- 644  TYPE  III  PNEU'MOCOCCUS  PNEUMONIA.  II 
cemia during the first 3 days, and the number of pulmonary lobes 
involved, in relation to recovery or death, are represented graphically 
in Chart 1.  The amount of pulmonary involvement was, in general, 
greater in the fatal cases than in those which recovered.  The salient 
features of the disease in the different groups are discussed in detail. 
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C~gx 1.  The relation of the height of septicemia and the amount of pulmonary 
involvement to the outcome of the disease. 
Group A.  Lobar Pneumonia without  Septicemia 
In this group of 8 animals, no demonstrable invasion of the blood 
had occurred at the time treatment was begun, which in 6 instances FRANCIS,  TERKELL,  DUBOS, AND  AVERY  645 
was on the 1st day, in 2 on the 2nd day after infection.  All 8 animals 
recovered.  The  average  weight  of  the  group  was  2130  gm.  The 
average  amount  of  culture  employed  for  inoculation  was  0.35  cc. 
In 2 cases there was involvement of three pulmonary lobes, in 1 case 
two lobes, while in the remaining 5 only one lobe was involved.  The 
average  duration  of the  disease was 3.2  days after infection.  This 
was estimated, to a great extent, upon the time when regression of the 
pneumonia was noted in the X-ray.  The temperature curve and the 
white blood count were of less value, since some febrile reaction and 
fall in the number of circulating leukocytes frequently followed admin- 
istration of enzyme.  When a rise in the number of leukocytes began, 
however, recovery was usually definitely established. 
No attempt was made to ascertain the minimal amount of enzyme 
required.  The  number of units of enzyme given to animals  in this 
group varied from  100 units  to 360,  and  the number of treatments 
varied from a  single dose  to four over a  period of 3 days.  In most 
instances, improvement began shortly after treatment was instituted. 
The monkey became more alert; there was a tendency for the fever to 
subside;  regression  of the  shadow,  most noticeable  at  the  margins, 
was observed in the  X-ray film. 
In comparison with the untreated animals  (1) without septicemia, 
the course of the disease in the treated animals was, on the average, 
of  shorter  duration.  Furthermore,  from  a  clinical  standpoint,  the 
animals of this group were, at the time treatment was begun, sicker 
than  those  of the  untreated  group,  and  the  amount  of pulmonary 
involvement was greater.  In some instances, it is possible that with 
a  spreading  pneumonia,  septicemia  and  death  might  have  occurred 
in the absence of treatment.  In no instance was a  prolonged illness 
noted,  although  one monkey, No. 4-2,  while  recovering from pneu- 
monia,  developed cutaneous sores and on the  6th day a  septicemia 
due  to Staphylococcus  aureus  and  a  Gram-negative  bacillus.  When 
sacrificed, the lungs showed definite resolution and the cultures from 
the pneumonic lobes revealed no pneumococci. 
Monkey 1-11 (Chart  2) was treated on the 2rid day after infection, when the 
right  upper lobe was completely involved.  At that  time the temperature  was 
high, but following a single treatment  with 50 units of enzyme there was a critical 
fall of the fever; no spread of the lesion occurred.  On the 3rd day another treat- 646 
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ment of the s~me amount was given.  On the 4th day resolution was evident in 
the  X-ray.  Recovery progressed uneventfully. 
Monkey  8-1 (Chart 3).  Treatment was begun on the Ist day of the disease, 
but  extension of  the  pneumonia was  noted in  the  X-rays on the  2nd and 3rd  days. 
On the  4th  day  resolution  was evident.  Roentgenograms taken  during the  course 
of the  disease  and recovery arc reproduced in Figs.  1 to 6. 
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C~RT 2.  Experimental pneumonia without septicemia, treated with enzyme. 
u.  represents units of enzyme. 
Group B.  Lobar Pneumonia with Septicemia 
(1-250 Colonies per Cc.) 
In this group of 15  animals the average weight was  1880 gin.,  the 
average amount  of  culture  used  was 0.37  co.  In  5  cases,  two pul- 
monary lobes were involved, in the remainder only one lobe.  Septi- 
cemia was present in  all instances,  the number of organisms present 
in the blood at the time of treatment ranging up to 166 colonies per 
1  cc.  of  blood  in  the  first  3  days  after  infection.  3  animals  were 654  TYPE  III PNEUMOCOCCUS  PNEUMONIA.  II 
treated onthe 1st day, 10 on the2nd, and 2 on the 3rd day after infec- 
tion.  The amount and duration of treatment varied from a: Single 
dose of 50 units on the 2nd day, to 5 treatments over the 2nd, 3rd, and 
4th days, with a total of 692 units.  In one case, No. 1-14, the blood 
culture contained 14 colonies per cc. on the 1st day, but was sterile 
on the 2nd day, when treatment was begun.  The only other example 
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CHART 3. Experimental pneumonia treated on 1st day of disease. 
of this course of events occurred in Monkey 1-1 of the untreated group, 
in which septicemia recurred and a fatal termination resulted.  In all 
but 2 cases the pneumonic process was clearly extending at the time 
of treatment. 
Treatment of this group of animals resulted in 100 per cent recovery, 
in contrast to 55 per cent recovery in the untreated group with com- 
parable septicemia.  The average time of recovery was 3.6 days after 
infection.  In 13 of the 15 cases, sterilization of the blood was effected ~RANCIS,  TE~RELL, DUBOS, AND AVERY  655 
by the  first  treatment,  in some instances within 4  hours.  In  one 
exception, the enzyme was found later to be contaminated, and Type 
III Pneumococcus was recovered in culture from the blood together 
with  a  Gram-negative bacillus.  In  spite  of  this,  resolution  began 
promptly and continued.  In the other case, the blood culture at the 
time of the first treatment was negative, but a  second culture taken 
2½ hours later was positive.  A third culture on the following day was 
negative.  In another animal, following therapy and while recovery 
was under way, an intercurrent superficial infection of the extremities 
was noted, and a Gram-negative bacillus was isolated from the blood. 
In 10, or possibly 11 cases, no spread of the pneumonic lesion was 
demonstrable by X-ray the day following the first treatment; in the 
majority, resolution was clearly seen.  In the 4 cases in which exten- 
sion of the lesion was noted the 1st day after treatment, there was no 
further  progression  as  treatment  was  continued.  Concomitantly 
with the improvement as shown by sterilization of the blood and de- 
crease in the size of the pneumonic process, there was usually a  fall 
in temperature, except in cases in which febrile reactions followed later 
injections of enzyme.  The animals also became stronger and more 
alert. 
In  comparison  with  similar untreated  cases  (1),  the  duration  of 
disease in the treated animals was, on the average, almost 1 day shorter 
than in the untreated animals which recovered, and 2  days shorter 
than  in  the  fatal  cases.  Of the  untreated  cases which  recovered, 
only 2 of 11 presented septicemia on the 1st day of disease, whereas 
of the 9 fatal cases, 7 had positive blood cultures on the 1st day.  The 
treated cases appear  to  be more comparable to  the latter animals, 
since of the 15 treated animals 13 had positive blood cultures the 1st 
day after infection, and, in general, higher septicemias than the fatal 
cases of the parallel untreated group.  The pulmonary involvement 
was comparable in that progressively spreading pneumonia of lobar 
distribution  was  present  at  the  time  of  treatment.  The  prompt 
subsidence of the septicemia and limitation of spread after treatment, 
together with general improvement, contrasts sharply with the course 
of the disease in the untreated series. 
Monkey 1-18 (Chart 4) represents the type of case in which two pulmonary 
lobes were involved early in  the disease and a  relatively high septicemia (60 656  TYPE III PNEUMOCOCCUS PNEUMONIA.  II 
colonies  per  cc.)  was present.  Treatment begun on the  2nd  day resulted  in 
prompt control of the pneumonia, and recovery of the animal. 
Monkey 9-2  (Chart  5)  illustrates  the  type of case in  which  treatment was 
begun on the 2nd day.  The blood, which  contained 16 colonies  per cc. at the 
time of  treatment,  was promptly sterilized,  but  the  X-ray  the  following  day 
showed some extension of the pneumonia.  There is the possibility that the spread 
2~.cynomolgos  No.i-IB  d  X4"ei~ht 1900 ~m.  Route  L~ 
C~ART 4.  Effect of enzyme on experimental pneumonia with mild septicemia. 
of the lesion seen in the X-ray on the 3rd day occurred in the interval of 6 hours 
between the time of the X-ray and the time treatment was begun.  Nevertheless, 
recovery rapidly followed. 
Group  C. Lobar Pneumonia  with  Septicemia 
(250-2000 Colonies per Cc.) 
This group comprises 9 animals in which the experimentally induced 
pneumonia was accompanied by a  high septicemia, ranging from the 
mildest case with 344 colonies per cc. of blood in the first 3 days after 
infection, to 2 cases with 1700 and 1728 colonies, respectively, during FKAI~CIS~ TERRELL, DUBOS, AND AVERY  657 
that period.  Needless to say, the degree of illness in this group was 
severe.  However,  8  of the  treated  animals  recovered,  giving a  re- 
covery  rate  of  88.9  per  cent.  This  contrasts  with  the  results  in 
untreated animals with similar severity of disease of which only 25 per 
cent recovered. 
The average weight of the animals was 1880 gin.; the average amount of culture 
injected was 0.39 cc.  In the 1 animal which died,  there was involvement of two 
.~.cy,'~o,'nolgoz  No.9-~  ~  Weight  2050 ~m.  RotLte i.h 
C~ar  5.  Experimental pneumonia with mild septicemia treated with enzyme. 
lobes the morning after infection, and a blood culture yielded 1040 colonies per 
1 cc. of blood.  A  treatment of 120 units  of enzyme was given 4] hours later, 
6 hours after the treatment, the septicemia was reduced to 160 colonies  per cc. 
At this time, the monkey had an attack of choking and died.  A search at autopsy 
revealed  no  tracheal  obstruction,  but  definite  pneumonic  consolidation  was 
present in  the right upper and lower lobes,  and Type III Pneumococcus was 
recovered from the pericardial fluid.  The spleen  was small and bound by dense 
adhesions. 658  TYPE  III PNEUMOCOCCUS  PNEUMONIA.  II 
In 2 d  the 8 recovered cases, two lobes were involved; in the remaining 6, only 
one lobe was affected.  In  6,  the leukocyte count  dropped below 5000  at  the 
height of the disease, and in one case to 1000, but at the beginning of recovery a 
definite rise occurred.  5 were treated on the 2nd day after infection, 2 on the 1st 
day, and one on the 3rd day.  Repeated treatments were given, the total amounts 
of enzyme varying from  177.$  units to 942  units.  Although  in 3 instances the 
degree of septicemia increased after treatment was instituted, in only 2 was there 
definite extension of  the pneumonia  after  treatment.  In  fact, in  4  cases  the 
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CHART 6.  Effect of enzyme on experimental pneumonia with moderately severe 
septicemia. 
roentgenograms revealed the beginning of resolution before the blood was cleared 
of organisms.  Furthermore, a  fall in temperature and an improvement in the 
general condition of the animals occurred at about the same time regression of the 
lesion was noted by X-ray, even though the septicemia might continue for several 
days (Monkey 8-0).  In general, in spite of the high septicemia, the action of the 
enzyme in effecting the sterilization of the blood was usually prompt and striking; 
the average time of recovery, based on final sterilization of the blood and X-ray 
evidence, was 5.4 days after infection. FRANCIS, TERRELL, DUBOS~ AND  AVERY  659 
To evaluate the effect of enzyme treatment in these animals, they 
may  be  compared  with  the  untreated  (1)  group  of  monkeys  with 
comparable pneumonia and septicemia. 
In  5  of the 9 fatal cases in the untreated group, the pneumonic pro- 
cess spread to involve three or more lobes.  Extension of the  pneu- 
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Cr~RT 7.  Experimental pneumonia with moderately severe septicemia treated 
on 2rid day of disease. 
moniawasgreatlylimited in the treated group.  In 6 of the untreated 
cases, empyema, pericarditis, or both, were found at  autopsy;  under 
treatment, these complications were  either prevented,  or, if present, 
(and  the  incidence in  the  untreated  would  suggest  the probability) 
they also responded favorably to  treatment.  In  the  treated  group, 
the degree of the septicemia at the time of treatment was consistently 
more severe than it was in the untreated animals at comparable times. 660  TYPE  III  PNEU~OCOCCUS  PNEUMONIA.  II 
The  results  in  this  group  of  animals  leave  little  doubt  of  the 
value  of  enzyme  therapy  in  experimental  Type  III  pneumococcus 
pneumonia. 
Monkey 7-2  (Chart  6)  showed pneumonic consolidation  of the  mid-portion 
of the right upper lobe on the 1st day after infection.  A blood culture  yielded 
1400 colonies of Type III Pneumococcus per cc. of blood, and the leukocytes had 
dropped to 4200 per c.mm.  The first  treatment, given 24 hours after infection, 
resulted  in a  prompt drop in  the septicemia.  Four treatments  in the next 48 
hours brought about prompt recovery.  Even on the 2nd day, when  the lesion 
was spreading  in part of the lobe, the original site of consolidation  was clearing. 
Monkey 1-29 (Chart 7) is an instance  in which  treatment was begun  on the 
2nd day after infection  when most of the right upper lobe was consolidated  and 
the septicemia  had reached  a  height of 1480 colonies per cc.  Four treatments 
during the next 2 days resulted in obvious resolution of the pneumonia, sterilization 
of the blood, and recovery. 
Group  D.  Lobar Pneumonia  with  Septicemia 
(More than 2000 Colonies per Co.) 
This group of 8 monkeys represents the extreme form of infection 
in which the tendency was toward a  diffuse pulmonary involvement, 
overwhelming septicemia,  extreme  fall in  white  blood count, failure 
in febrile response,  and early death.  Nevertheless,  of the 8  treated 
cases,  1 recovered, a  mortality rate of 87.5 per cent. 
The average weight of the animals was 1820 gin., varying from 1200 to 3025 gin. 
The average amount of inoculum was 0.46 cc. of Type III pneumococcus culture. 
In the fatal cases the average  duration of the disease was 3 days.  In 2 of the 
group, only one pulmonary lobe was involved;  in the others three or more lobes 
were affected.  In 6 of the 8 cases, Pneumococcus  III was recovered  from the 
pleural  or pericardial  fluid, or both.  In 3 cases the septicemia  was below 4000 
colonies per 1 cc. of blood, in the remainder it ranged from 18,000 to innumerable 
colonies at  the  time  treatment  was  begun.  In inverse  ratio  to  the degree  of 
septicemia,  the circulating leukocytes  were severely depressed to 2000 or less per 
c.mm.  The animals rapidly collapsed, and any therapeutic  aid seemed hopeless. 
The amount of enzyme administered  varied from 130 units in 1 animal to 615 
units in the recovered case.  In 3 instances,  only one dose of enzyme was given, 
and in 3 others repeated doses of relatively  small amounts were given.  In the 
latter animals,  distinct effects were noted, and possibly  with larger  amounts of 
enzyme recoveries might have resulted. 
Despite  the forbidding  aspects  of the disease,  one animal  with  involvement }'RANCIS, TERKELL,  DUBOS  ~ AND  AVERY  661 
of the right upper lobe and a septicemia  of 3800 colonies at the time of the first 
treatment on the 2nd day recovered.  In 2 cases with 18,000 and 25,000 colonies 
at  the time  treatment was  begun,  the  septicemia  was  markedly reduced,  the 
spread of the pneumonia checked, and life prolonged until the 5th and 4th days, 
respectively.  In  2  others,  although  death  occurred  early,  single  treatments 
caused a  marked diminution in the number of pneumococci  in  the circulating 
blood. 
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C~a~T 8.  Effect of enzyme therapy in promoting the cessation of pneumonic 
extension,  diminution  of septicemia,  and  prolongation of life  in  experimental 
pneumonia with overwhelming  septicemia. 
The disease in this group of animals is much the same as that in the 
untreated  (1)  group with comparable septicemia,  in which the mor- 
tality  rate  was  100  per cent.  In  comparing the  degree of involve- 
ment in the two groups, the treated animals had, in a higher percent- 
age, three or more lobes involved.  However, animals suffering from 
pneumonia  of  such  pronounced  form  are,  because  of  the  marked 662  TYPE  III PNEUMOCOCCUS PNEUMON/_A.  II 
general depression and rapidly fatal outcome, dearly unsatisfactory 
for therapeutic  experiments. 
Monkey 3-9 (Chart 8) illustrates  the effect of enzyme therapy in a  case with 
marked septicemia which terminated fatally.  The spread of the pneumonia was 
checked, a  substantial  reduction in septicemia was effected, and life prolonged. 
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CHART 9.  Experimental  pneumonia  with  marked  septicemia,  treated  with 
enzyme but terminating fatally. 
At autopsy, the left lower lobe was completely consolidated, while the left middle 
and  right lower lobes appeared  congested.  Fibrinopurulent  pleurisy and  peri- 
carditis were present. 
Monkey 1-17  (Chart  9) is an instance in which the pneumonia continued to 
spread, the septicemia increased, and death occurred on the 3rd day after infection. 
Autopsy revealed lobar pneumonia of the right upper and middle lobes, and partial 
consolidation of the fight lower lobe.  A fibfinopurulent pleurisy was present over 
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In Monkey 1-30 (Chart 10), which had well marked consolidation  at the time 
of treatment and 3800 colonies  of Type III Pneumococcus  in culture per i cc. of 
blood, treatment caused prompt limitation of the pneumonia, and two days later 
ste~.lization of the blood.  Recovery  followed.  Roentgenograms are  shown in 
Figs. 13 to 18. 
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CHART 10.  Experimental pneumonia with  marked  septicemia which recov- 
ered after enzyme therapy. 
DISCUSSION 
The results of specific enzyme therapy in the experimental Type III 
pneumococcus  pneumonia  of  monkeys  have  been  presented.  To 
evaluate  the  effects of treatment in  the  present  series of animals, 
the  results,  as  measured by recovery or  death,  may be  compared 
with those in an untreated series of animals (1)  included in the pre- 
ceding paper (Table III).  It must be borne in mind, however, that 
in a given experiment the animals which appeared sickest were selected 
for treatment.  Of those animals, treated or not, in which no bac- 664  TYPE  III  PNEUMOCOCCUS  PNEUMONIA.  II 
terial invasion of the blood was demonstrable, all recovered.  In the 
group with pneumonia accompanied by septicemia of I to 250 colonies 
per cc. of blood, 45 per cent of the 20 untreated animals died, while 
all of the 15 treated monkeys recovered.  Of the 12 untreated animals 
in the group with septicemia ranging from 250 to 2000 colonies per cc., 
75 per cent died, whereas of 9 animals which received enzyme therapy, 
only I died, a mortality rate of I 1.I per cent.  The final group includes 
the animals which suffered from an  extremely pronounced  form of 
infection, frequently with  diffuse  pneumonia,  rapid  exhaustion  of 
TABLE  III 
The Influence of Enzyme Therapy upon Mortality Rate in Experimental Type III 
Pneumococcus Pneumonia in Monkeys* 
Class of infection 
Pneumonia without septicemia ..... 
Pneumonia with septicemia (1-250).. 
Pneumonia  with  septicemia  (250- 
20OO). 
Pneumonia  with  septieemia(2OOO-b). 
Total... 
Total for groups with septicemia... 
Untreated 
No. 
of 
ani- 
mals 
20 
20 
12 
16 
68 
48 
No. 
re-  No. 
coy-  died 
ered 
2O  0 
11  9 
3  9 
0  16 
34  34 
14  34 
MortaHty 
~er Ce~ 
o 
45"0156  2 
75.oj  " 
i00.0 
50.0 
70.8 
Treated 
No.  No. ] 
of  re-  ! No.  Mortality  ani-  cov-I died 
reals  ered 
per cent 
8  8  0  0 
15  15  0  0  14 
J  9  8  1  11.1 
8  1  7  87.5 
40  32  8  20.0 
32  24  8  25.0 
* Classified on the basis of height of septicemia in first 3 days. 
circulating leukocytes, septicemia of very high  degree,  and  with  a 
tendency to  early death.  In the 16 untreated animals of this group, 
the mortality rate  was  100  per cent.  Of 8 comparable monkeys to 
which enzyme was administered, 7 died, and 1, in which the septicemia 
reached 3800 colonies per cc. before treatment, recovered, a mortality 
rate of 87.5 per cent. 
It can readily be seen that in the groups in which no invasion of the 
blood  occurs,  spontaneous  recovery  is  to  be  uniformly  expected, 
whereas in the extremely severe forms of the disease the great majority 
of animals are too completely  prostrated to respond to any therapeutic FRANCIS, TERRELL~  DUBOS,  AND  AVERY  665 
aids.  Consequently, the two intermediate groups appear to offer the 
best  opportunity for  studying the effects of enzyme therapy.  In- 
cluded in these groups in which septicemia ranged from 1 to 2000 
colonies per cc.  are  32  untreated monkeys of which 18  died  (56.2 
per cent), and 24 treated animals with only one death (4 per cent). 
Or, if one compares the results in all animals in which septicemia was 
present, 70.8 per cent of 48 untreated animals died, but only 25 per 
cent of the 32 treated animals. 
In addition to the apparently beneficial effects of specific enzyme 
therapy as measured by survival or death of the animals, certain other 
favorable influences were observed.  In a  high percentage of cases 
in which extension of the pneumonic  process was occurring at the time 
of  treatment,  the  spreading promptly ceased  following the  initial 
injection of enzyme.  Although the density of the area of consolida- 
tion might at first appear greater than before treatment, extension 
did not occur and resolution of the lesion soon began.  This limitation 
of spread of the pneumonia was not infrequently noted in the severe 
cases before the bacteria were completely eliminated from the blood 
stream  (Figs.  7  to  12).  A  comparison  of  the  ultimate  degree  of 
pulmonary involvement  in  the  treated  and  untreated  cases  (1) 
(Chart 1)  reveals the fact that it was less, in general, in the former 
series.  While  in  the  treated  cases  the  extension  was  apparently 
limited early, in the untreated animals extension of the pneumonia 
progressed, frequently with fatal results. 
That the administration of enzyme promoted sterilization of the 
blood stream seems certain.  In the milder cases this occurred quite 
rapidly.  In animals in which the higher degrees of septicemia were 
present, there was rarely an increase, more regularly a  prompt de- 
crease  in  the  number of pneumococci in  the  blood  following the 
administration  of  enzyme.  Even  in  cases  which  eventually  ter- 
minated fatally, or in which extreme septicemia occurred early in the 
disease,  cultures of the  blood  showed a  marked  reduction  in  the 
number of bacteria within 4 to 5 hours after the first treatment. 
Simultaneously with limitation of the pneumonia, beginning resolu- 
tion,  and  elimination of  septicemia,  a  fall  in  temperature usually 
occurred.  In fact,  there was  a  tendency for  the  fever to  subside 
concurrently with the cessation of pneumonic spread, even though 666  TYPE III PNEU3~OCOCCUS  PNEU3~ONIA.  II 
septicemia still persisted.  Although a marked leukopenia was com- 
paratively frequent at the time treatment was begun, the number of 
leukocytes rose with the beginning of recovery. 
In fatal untreated cases with septicemia, a high incidence of positive 
cultures was obtained from pleural or pericardial fluids at autopsy. 
In many instances frank empyema or pericarditis was present.  In 
the treated cases with severe infections which resulted fatally,  the 
incidence of these complications was also high.  In recovered animals 
of the treated series, therefore, a frequency of suppurative complica- 
tions equal to that of the untreated animals might be expected.  The 
fact that the treated animals which survived recovered without sup- 
purative sequelae suggests that enzyme therapy either prevented the 
development of  empyema and  pericarditis  or  was  therapeutically 
effective even in the presence of these complications. 
As  previously stated,  many  technical  difficulties have  been  en- 
countered in attempting to produce enzyme preparations of uniformly 
high therapeutic activity and purity.  The different lots of enzyme 
have, as a  result, been inconstant in both these respects.  In some 
instances  toxic  effects,  attributable  to  impurities in  the  material, 
have  been  noted  in  animals  after  the  administration  of  enzyme. 
These impurities may induce a febrile reaction and a decrease in the 
white blood count of the animal.  At other times, when the animal 
is extremely ill with subnormal temperature and a marked leukopenia, 
the  administration of impure preparations may produce  a  further 
depression of temperature and of the leukocytes. 
The results of the present study indicate that the specific enzyme, 
even  in  its present state  of purity,  exerts  a  favorable  therapeutic 
effect upon the course and outcome of experimental Type III pneumo- 
coccus pneumonia in monkeys.  Nevertheless, the present study again 
emphasizes  the  therapeutic  limitations  of  the  enzyme  (4).  The 
action of the enzyme is known to be exerted upon the capsular poly- 
saccharide of Type III Pneumococcus (6).  By being deprived of its 
capsule, the  bacterium is made susceptible to phagocytosis by  the 
cells of the animal body.  However, when the disease process is of 
extreme severity and the entire cellular mechanism of the body is 
markedly depressed, the animal may no longer possess the capacity 
to dispose of the organisms rendered vulnerable by the specific action 
of the enzyme. FRANCIS, TERRELL, DUBOS, AND  AVI/~RY  667 
SUMMARY 
The effects of specific enzyme therapy upon experimental Type III 
pneumococcus  pneumonia  in  monkeys  were  studied  by  comparing 
the course and outcome of the disease in treated animals with that in 
animals which received no therapeutic aid.  Enzyme treatment was 
found to exert a distinctly favorable influence upon the experimental 
pneumonia.  Treatment was followed by cessation of spread of the 
pneumonic  lesion,  sterilization  of  the  blood,  and  early  recovery, 
except in animals in which the severity of the disease was extreme. 
While in  the  untreated  animals a  high incidence  of  empyema and 
pericarditis  was  observed,  suppurative  sequelae  were  apparently 
prevented  by  adequate  enzyme  therapy.  The  limitations  of  the 
therapeutic action of the specific enzyme in the presence of marked 
depression  of  the  cellular  reaction  in  infected  animals  are  again 
emphasized. 
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EXPLANATION OF PLATES 
PLATE 48 
Roentgenograms of Monkey 8-1 during the course of experimental  pneumonia, 
treated the 1st day after infection (Chart 3). 
FIC.  1.  Control.  Before  inoculation (Dec. 19). 
FIC. 2.  (Dec. 20.)  19 hours after infection and 7 hours before the first treat- 
ment, showing well localized consolidation in lower half of the right upper lobe. 
FIc. 3.  2nd day (Dec. 21), showing extension of pneumonia throughout right 
upper lobe. 
FIG. 4.  3rd day (Dec. 22), showing increased  density of the shadow over the 
right upper lobe, but no evidence of further spread. 
FIG. 5.  5th day (Dec. 24).  Resolution of the pneumonia has begun, as shown 
by the decrease in density and beginning aeration of the area. 
FIC. 6.  10th  day (Dec.  29), showing complete  resolution of the pneumonic 
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P~ATE 49 
Roentgenograms of Monkey 9-4 during the course of the disease and recovery 
(Table II). 
FiG.  7.  h~t day after infection  (Feb.  7), showing  a  well marked early pneu- 
monia of the lower part of the right upper lobe. 
FxG. 8.  2nd day (Feb. 8), showing  extension of the lesion  through the entire 
right upper lobe, and a small early shadow in the right cardiohepatic angle.  Treat- 
ment begun. 
FIG. 9.  3rd day (Feb. 9).  Shows no extension, perhaps some clearing of shadow 
in right cardiohepatic angle. 
Fro.  10.  4th day (Feb. 10).  Aeration beginning,  as evidenced by the clearly 
outlined base of heart. 
FIG. 11.  5th day (Feb. 11).  Base of heart drawn well to right toward resolving 
lobe, a feature not infrequently noted. 
Fro. 12.  1 week later (Feb.  18).  Almost complete resolution. 
PLATE 50 
Roentgenograms of Monkey 1-30, first treated on the 2nd day after infection 
when septicemia had reached 3800 colonies per cc. (Chart 10). 
FIG. 13.  Control plate (June 5).  Shows heart rotated to the right side.  Evi- 
dence of the extreme mobility of the mediastinum often noted. 
Fro. 14.  1st day of disease (June 6), showing early lesion in the lower part of 
the right upper lobe. 
Fro. 15.  2rid day (June 7), showing extension of lesion. 
FIG. 16.  3rd day (June 8, following treatment).  There is a decrease in density 
of the shadow,  suggesting early resolution. 
FIGs. 17, 18.  4th and 5th days (June 9 and 10), showing regression of the lesion. THE JOURNAL OF EXPERIMENTAL MEDICINE VOL. 59  PLATE 48 
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